Spotlight: JP Morgan 2026


LIVE COVERAGE

January 12-15, 2026 | San Francisco, CA

2026 J.P. Morgan Week


Last year’s JP Morgan conference in San Francisco fell in the midst of a United States leadership transition, and the mood was one of unprecedented uncertainty. A year later, the future still isn’t crystal clear, but biotech is back to something like normality, and the big deals are already happening.

Once again, pharmaphorum editor-in-chief Jonah Comstock will be on-site in San Francisco, reporting from the Informa Biotech showcase, the Sachs Oncology and Neuroscience Forums, a smattering of smaller events, and – of course – a bevy of video interviews with interesting pharma and biotech leaders.

Check back on this landing page for daily updates from the show starting on Sunday 10th January. We’ll cover all the hot topics from US policy to AI and GLP-1s. And, of course, we’ll be taking a close look at the investment and dealmaking environments. Don’t forget to follow us on LinkedIn and BlueSky for even more updates, too.

Nicole Raleigh

Reported by Jonah Comstock

Jonah Comstock is a veteran health tech and digital health reporter. In addition to covering the industry for nearly a decade through articles and podcasts, he is also an oft-seen face at digital health events and on digital health BlueSky.

Highlights from the past JP Morgan conferences

R&D
JPM25 Steve Pakola interview with Jonah Comstock

JP Morgan Week 2025 – Steve Pakola

On the sidelines of JP Morgan in San Francisco, editor-in-chief Jonah Comstock caught up with Steven Pakola, REGENXBIO’s chief medical officer.

R&D
wooden block with 5 on

5 takeaways from JP Morgan 2025

I’m back from another week in San Francisco, where as usual I heard from experts and prognosticators about their expectations for the coming year in biotech.

R&D
Neural network vector illustration

JP Morgan Week 2025 - Day 3

pharmaphorum's JPM Week live blog finishes strong with panels on AI, funding, and a conference wrap-up.

R&D
Neural network vector illustration

JP Morgan Week 2025 - Day 3

pharmaphorum's JPM Week live blog finishes strong with panels on AI, funding, and a conference wrap-up.

R&D
Neural network vector illustration

JP Morgan Week 2025 - Day 2

On day 2 of pharmaphorum's JPM Week blog, we'll hear from leaders from the President of Novartis, a stacked industry panel on AI, and Dr Jill Biden.

R&D
Neural network vector illustration

JP Morgan Week 2025 - Day 2

On day 2 of pharmaphorum's JPM Week blog, we'll hear from leaders from the President of Novartis, a stacked industry panel on AI, and Dr Jill Biden.

R&D
Neural network vector illustration

JP Morgan Week 2025 - Day 1

On day 1 of JPM Week, join pharmaphorum as we hear about pharma's dealmaking plans and the changing pharma landscape.

R&D
Neural network vector illustration

JP Morgan Week 2025 - Day 1

On day 1 of JPM Week, join pharmaphorum as we hear about pharma's dealmaking plans and the changing pharma landscape.

R&D
JP Morgan 2024 – Sam Deutsch

JP Morgan 2024 – Sam Deutsch

In another lightning round JP Morgan interview, editor-in-chief Jonah Comstock caught up with Sam Deutsch, CEO of Nutcracker Therapeutics, to talk briefly about the company’s lead asset for cervica

R&D
JP Morgan interview with Jonah Comstock and Marianne De Backer

JP Morgan 2024 – Marianne De Backer

Vir Biotechnology made headlines in 2021 for its work with GlaxoSmithKline on a treatment for COVID-19, and again in 2022 for its work with the US government on influenza.

Digital
JP Morgan 2024 – Simon Arkell interviewed by Jonah Comstock

JP Morgan 2024 – Simon Arkell

Generative AI – large language models, or LLMs, like ChatGPT – has the potential to revolutionise almost any knowledge industry, and pharma is no exception.

R&D
JP Morgan 2024 – Katherine Stueland and Jonah Comstock

JP Morgan 2024 – Katherine Stueland

Diagnostics can be a neglected part of the treatment paradigm, but it’s hugely important for connecting patients with the right treatments.

R&D
Jonah Comstock and Frank Gleeson at JP Morgan

JP Morgan 2024 – Frank Gleeson

In this brief dispatch from JP Morgan, Editor in Chief Jonah Comstock grabs a few minutes with Frank Gleeson, CEO of Satellos Bioscience. 

R&D
JP Morgan 2024 – Jen Nwankwo

JP Morgan 2024 – Jen Nwankwo

While 2023 may have been the year of AI for the consumer consciousness, for companies using the technology in a focused way in drug development it was just another year of learning and adva

R&D
JP Morgan 2024 – Graham Heap

JP Morgan 2024 – Graham Heap

Just over a year ago, Takeda acquired a promising immunotherapy candidate, TAK-279, from Boston-based Nimbus Therapeutics.

Digital
pharmaphorum podcast episode 109

Key themes from JP Morgan

pharmaphorum editor-in-chief Jonah Comstock is back from San Francisco, where he attended the annual JP Morgan Healthcare Conference.

R&D
JP Morgan 2024 – Jeff Smith

JP Morgan 2024 – Jeff Smith

Editor-in-chief Jonah Comstock sat down with Jeff Smith, chief research officer at Precision BioSciences, on the side lines of the JP Morgan Healthcare Conference in San Francisco to discus

Market Access
Six takeaways from JP Morgan 2024

Six takeaways from JP Morgan 2024

With another JP Morgan in the rearview mirror, it’s time to take stock of the announcements, the presentations, and, above all, the vibes.

R&D
JP Morgan 2024 live event coverage Day 2

JP Morgan Week 2024 - Day 2

Our second and final day of JP Morgan Week coverage will be Wednesday, and once again pharmaphorum editor-in-chief Jonah Comstock will be bringing you updates from Fierce JPM Week and Informa Biote

R&D
JP Morgan 2024 live event coverage Day 1

JP Morgan Week 2024 - Day 1

After a Monday full of one-on-one meetings and video recordings, Tuesday will see pharmaphorum editor-in-chief Jonah Comstock starting the day at Informa’s Biotech Summit, where he’ll report on ses

R&D
JP Morgan 2024 live event coverage Day 1

JP Morgan Week 2024 - Day 1

After a Monday full of one-on-one meetings and video recordings, Tuesday will see pharmaphorum editor-in-chief Jonah Comstock starting the day at Informa’s Biotech Summit, where he’ll report on ses

R&D
JP Morgan 2024 live event coverage

JP Morgan Week 2024

It’s the new year, and that means the JP Morgan Chase healthcare conference is upon us once again.

R&D
JP Morgan 2024 live event coverage

JP Morgan Week 2024

It’s the new year, and that means the JP Morgan Chase healthcare conference is upon us once again.

About JP Morgan Healthcare Conference

This premier conference is the largest and most informative health care investment symposium in the industry, which connects global industry leaders, emerging fast-growth companies, innovative technology creators, and members of the investment community.